Government in business rarely if ever goes well. I've never found a successful government ran Corporation that was also publicly traded.
As for cannabis, there's no clear winners in that industry right now and with so much regulation and soooo much debt most are carrying most of those companies aren't going to turn a profit for a long time. I'm all for investing and believe that cannabis as an industry can be great for states and cities not only for jobs but for other socioeconomic reasons as well. Cannabis will be successful in the long run I'm confident in that.
The fool can be a great resource but you have to really exercise critical thinking with those articles because many of them do not give good information and often times it's outdated, incorrect or the writers have biased opinions.
Harvest is cheap relative to book value but it isn't making money and actually hasn't in nearly yet, I looked at the last 4 quarters and it's a mess. In 2018 they reported a massive quarterly loss of $67 million and in 2020 I doubt they'll change that. The balance sheet is mostly just cash (likely from bank loans and/or investors cash and if shit hits the fan they couldn't sell off assets to keep the lights on so they're going to have to borrow more money to stay afloat until they begin turning a profit. My only critique is they listed "Goodwill" as being worth some money lmao (that's not even real btw they're basically saying their name is worth that money when really it means nothing - I never count goodwill unless you're say Coca cola, Procter and Gamble or something). Aside from that they're selling at a 40% discount to their true net worth. Personally I wouldn't go near it with a 10 foot pole because it's not making any money and there's no clear catalysts that can organically push it to growth.
Curaleaf is even worse, it sells at 5x it's price to book value, makes no money and I can tell their entire balance sheet looks like money loaned to them which means they don't actually have any real assets aside from cash. I wouldn't go near this either.
Bruh......FrI say let the ETF and Low Cost Index Fund professional handle it. Long term looking back, this is a great opportunity (Vanguard)
We need to start our ownREITS
Break it down for us simpletonsThis is insane.
The very medicine that puts you at risk us the same medicine that could save your life.
Like frfr
Wtf
Ms medicines helps the body repair the lining around your nerves. With MS that lining around your nerves is attacked and destroyed by cells in your body. The medicine helps your body repair the lining but the exchange is it has to lower your immune system.Break it down for us simpletons
The Lord giveth and the Lord taketh away. How beneficial is it if it makes you that susceptible to viruses? This is one of the reasons I'm not invested in pharmaceuticals because i know nothing about it.Ms medicines helps the body repair the lining around your nerves. With MS that lining around your nerves is attacked and destroyed by cells in your body. The medicine helps your body repair the lining but the exchange is it has to lower your immune system.
A lower immune system make you more vulnerable to any and all viruses.
The coronavirus sars in the past was controlled with certain medicines. Some of those medicines are medicines that also treat MS.
So while it lowers your immune system and makes you vulnerable to a virus...That same medicine could cure or treat the symptoms of the virus.
Crazy.
I love science almost as much as I love new coochie.
Been a while since I had new coochie...
.So I'm deep in science.
Man pharma is crazy.The Lord giveth and the Lord taketh away. How beneficial is it if it makes you that susceptible to viruses? This is one of the reasons I'm not invested in pharmaceuticals because i know nothing about it.
Preciate the infoInovio shares rally after biotech says human trials of coronavirus vaccine will start in April
Shares of Inovio Pharmaceuticals Inc. rallied more than 16% Tuesday, after the company said it’s accelerating the timeline for development of a vaccine to...www.marketwatch.com